1. Home
  2. LXRX vs FBIZ Comparison

LXRX vs FBIZ Comparison

Compare LXRX & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • FBIZ
  • Stock Information
  • Founded
  • LXRX 1995
  • FBIZ 1909
  • Country
  • LXRX United States
  • FBIZ United States
  • Employees
  • LXRX N/A
  • FBIZ N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • FBIZ Major Banks
  • Sector
  • LXRX Health Care
  • FBIZ Finance
  • Exchange
  • LXRX Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • LXRX 352.5M
  • FBIZ 404.0M
  • IPO Year
  • LXRX 2000
  • FBIZ N/A
  • Fundamental
  • Price
  • LXRX $0.75
  • FBIZ $48.65
  • Analyst Decision
  • LXRX Buy
  • FBIZ Strong Buy
  • Analyst Count
  • LXRX 2
  • FBIZ 4
  • Target Price
  • LXRX $6.00
  • FBIZ $51.75
  • AVG Volume (30 Days)
  • LXRX 4.9M
  • FBIZ 21.8K
  • Earning Date
  • LXRX 11-12-2024
  • FBIZ 01-23-2025
  • Dividend Yield
  • LXRX N/A
  • FBIZ 2.06%
  • EPS Growth
  • LXRX N/A
  • FBIZ 6.29
  • EPS
  • LXRX N/A
  • FBIZ 4.64
  • Revenue
  • LXRX $5,229,000.00
  • FBIZ $140,240,000.00
  • Revenue This Year
  • LXRX $886.38
  • FBIZ N/A
  • Revenue Next Year
  • LXRX $181.58
  • FBIZ $8.01
  • P/E Ratio
  • LXRX N/A
  • FBIZ $10.43
  • Revenue Growth
  • LXRX 886.60
  • FBIZ 3.59
  • 52 Week Low
  • LXRX $0.62
  • FBIZ $32.56
  • 52 Week High
  • LXRX $3.73
  • FBIZ $52.22
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 38.05
  • FBIZ 47.27
  • Support Level
  • LXRX $0.72
  • FBIZ $48.32
  • Resistance Level
  • LXRX $0.85
  • FBIZ $50.38
  • Average True Range (ATR)
  • LXRX 0.09
  • FBIZ 0.85
  • MACD
  • LXRX 0.03
  • FBIZ -0.34
  • Stochastic Oscillator
  • LXRX 33.10
  • FBIZ 12.36

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, focusing on delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: